Will Garvin, shareholder in the firm's Life Sciences industry and co-chair of the firm’s Cannabis practice group, was quoted in Modern Healthcare article, “Providers face increased legal risk as FDA ends emergency use.”
We follow industry news and trends so you can stay ahead of the game. Subscribe to receive emails regarding policies and findings that impact you and your business.
Already a subscriber and want to update your preferences? Click here.